# Phase 10E — Negative closeout

## Conclusion

T-147 closes on the researcher-accepted `remain_advisory` disposition. The task delivered the
product-owned evidence, gap, question, and promotion checkpoint control plane (A1–A8) and one
early-gap Research Arena that is optional and support-only. It did not prove that the Arena
improves production decisions, and it does not activate or generalize the Arena.

This is a successful negative closeout: the evidence was insufficient for activation, the system
said so without promoting the frozen moderate topic or manufacturing calibration members, and the
accepted task boundary now matches that result.

## Decisive evidence

- Canonical Phase 10A run
  `offline_eval_run_d64bd0c4-8074-4474-bf41-d9c6ef51bfe1` still reports
  `insufficient_evidence`, `product_v2_member_count=0`, zero strict-human labels, 12 coverage
  gaps, and `support_only=true` at technical trace hash
  `143a4639c8b8c0ba964d109226a5f3b9715ba3620e72ad9a54e5afc26cf8847f`.
- Its normalized API report hash remains
  `27b85487031668572a723167eb336d0044d3021a2b6921444acb2b4d1cec9b9d`.
- Current Arena session
  `research_arena_def21744-92fb-41cb-96f1-20798e76392a` remains `synthesized`,
  `support_only=true`, and terminated as `evidence_expansion_required`; it has not been made an
  authority.
- Phase 10B stopped before protocol freeze or case registration because no fresh lineage satisfied
  exact evidence resolution, retry capacity, current checkpoint, and v2 recipe eligibility
  together. It created zero cases, sessions, role outputs, labels, provider calls, or research
  authority writes.
- Phase 10C applied the unchanged predeclared rule and recorded `remain_advisory`; Phase 10D was
  therefore skipped.

## Acceptance disposition

| Reference | Phase 10E disposition |
|---|---|
| A1–A8 | Delivered and previously verified: the product-owned checkpoint control plane, human authority, objections, risk obligations, API recovery, cutover, and regression coverage are complete. |
| A9 | Not completed and intentionally not forced. The coherent-but-moderate lineage remains frozen with zero PromotionDecision and zero bridge; a fresh post-bridge positive proof is not part of the accepted closeout. |
| A10 | The product-v2 evidence/execution/replay contract is implemented and verified. A live product-v2 lineage replay was not demonstrated and is not claimed. |
| A11 | Zero-to-many and select/park/drop/reframe/expand disposition contracts are implemented in support-only mode. Production adoption and decision-quality effectiveness were not demonstrated. |
| A12 | Stable dissent/risk carry and projection through promotion are implemented and verified. The effect of an activated Arena policy was not tested because activation was not selected. |
| A13 | Not demonstrated. Missing dominance pairs, perturbations, strict-human labels, and measured decision/work-avoided outcomes directly require `remain_advisory`. |

## Preserved boundaries

- `HumanConfirmNeed` remains the sole gap-selection research authority; Arena synthesis cannot
  select, drop, advance, or block production state.
- No policy version changed, no new topic chain ran, no provider was invoked, and no checkpoint,
  candidate, human decision, promotion, bridge, or PaperProject authority was written in Phase
  10E.
- The current promotion gate
  `promotion_gate_check_39bfb045-47d2-4e67-b6b4-f9a125aa88be` and its moderate lineage remain
  frozen rather than being promoted for process completion.
- T-147 remains under `dev-docs/active/` with `State: done` until an independently authorized
  archive transition.

## Reopen conditions

Production activation is not a remaining T-147 action. It requires all of the following under a
separate tracked and reviewed change:

1. an explicit evidence or protocol delta, including resolution of TS-I18 corpus eligibility and
   TS-I19 initial product-v2 snapshot preparation;
2. at most one separately reviewed calibration batch with product-v2 members, exact strict-human
   labels, dominance and both perturbation directions, and complete accounting;
3. a new source-bound report showing a real decision improvement or measured downstream work
   avoided, with no hard-fail invariant breach; and
4. a new researcher-owned adoption decision.

T-129 retains provider/prompt calibration ownership. T-147 neither performs nor unblocks that
work, and no new follow-up task is created by this closeout.

## Evidence identity

| Source | SHA-256 |
|---|---|
| `phase10a-current-corpus-calibration.md` | `b0dc761511f6b61ab2bb8f39038c12fa9920eba822ca9cb8c78d005b197dae1e` |
| `phase10a-current-corpus-calibration-llm.json` | `fdd048774de1a0552121e82709bbb14fd1874c49315004ba008ef11463bdf69c` |
| `phase10b2-corpus-eligibility-stop.md` | `8844c9cf88016bd647b27f7deff86a68392b8187162237fc72725d93397e1e3c` |
| `phase10b2-corpus-eligibility-stop-llm.json` | `a18fcfe78b9fd1eea9e87defacc43c3ad5aef9a598fb4bebe98cbc8bfb01cce9` |
| `phase10c-adoption-decision.md` | `2c9d450992c7c9306becd151333557256a0dde916726e96b5f15a04ad5d9b97d` |
| `phase10c-adoption-decision-llm.json` | `8b6b296976691a7c08adae33b9631f545aa8d75093f470fb1742e040bfd78561` |

## Researcher authority

The researcher approved the revised negative-closeout route and execution with: “按此修订并执行
Phase 10E”. This acceptance authorizes reconciliation of A9–A13 and task completion on the narrowed
outcome; it does not authorize production activation, provider work, a new calibration batch, or
task archival.
